IGC Pharma Announces Positive Interim Results In Reducing Alzheimer’s Agitation At Benzinga's Virtual Healthcare Summit
  • last month
This company is dedicated to transforming the landscape of healthcare, particularly focusing on the development of innovative therapies aimed at treating neurological disorders, such as Alzheimer’s disease. They are driven by a mission to enhance the quality of life for millions of individuals affected by these challenging conditions. Alongside their commitment to neurological health, they are equally devoted to advancing women’s health, addressing the unique needs that arise throughout the various stages of life. The company’s overarching goal is to offer substantial relief to those suffering from these health issues, while also contributing to the broader understanding and treatment options within these critical areas of healthcare.
Recommended